Research and Markets (http://www.researchandmarkets.com/research/m25g6b/global_cervical) has announced the addition of the "Global Cervical Cancer Epidemiology and Patient Flow Analysis - 2015" report to their offering.
This report provides insights into Cervical Cancer epidemiology, Cervical Cancer diagnosed patients, and Cervical Cancer treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Cervical Cancer derived from epidemiological analysis, percentage of patients diagnosed with Cervical Cancer, and percentage of patients treated with Cervical Cancer therapy.
The study helps executives estimate Cervical Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Cervical Cancer prevalence, Cervical Cancer diagnosis rate, and Cervical Cancer treatment rate for the period 2014 - 2020. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
Key Topics Covered:
1. Cervical Cancer: Disease Definition
2. Global Cervical Cancer Patient Flow
3. Cervical Cancer Patient Flow in the US
4. Cervical Cancer Patient Flow in Europe
5. Cervical Cancer Patient Flow in Germany
6. Cervical Cancer Patient Flow in France
7. Cervical Cancer Patient Flow in Spain
8. Cervical Cancer Patient Flow in Italy
9. Cervical Cancer Patient Flow in UK
10. Cervical Cancer Patient Flow in Japan
11. Appendix
For more information visit http://www.researchandmarkets.com/research/m25g6b/global_cervical
